Drug for Psoriasis can be deadly; Raptiva linked to fatal neurological disease
Raptiva (or efalizumab), a psoriasis drug, may cause a serious brain infection and even result in death. The Food and Drug Administration on Feb. 19 issued an advisory citing three confirmed cases — and a possible fourth case — of persons being diagnosed with progressive multifocal leukoencephalopathy (PML) after they were treated with Raptiva. The…
Continue reading